Evidence map›Paper›PMID 34459144›Full record

ArticleClinical and translational medicine2021

Inherited GATA3 variant associated with positive minimal residual disease in childhood B-cell acute lymphoblastic leukemia via asparaginase resistance.

Chunjie Li, Wenyi Liang, Yingyi He, Xinying Zhao, Jiabi Qian, Ziping Li, Chuang Jiang, Qingqing Zheng, Xiangmeng Fu, Weina Zhang and 4 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Frontiers in oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Chunjie LiDepartment of Hematology/Oncology, Affiliated Guangzhou Women and Children's Medical Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Wenyi LiangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Yingyi HeDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Xinying ZhaoDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Jiabi QianDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Ziping LiDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Chuang JiangShanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Qingqing ZhengDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Xiangmeng FuDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Weina ZhangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Haiyan LiuDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Xin SunDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Maoxiang QianInstitute of Pediatrics and Department of Hematology and Oncology, Children's Hospital of Fudan University, National Children's Medical Center, the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Hui ZhangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.ORCID 0000-0001-8791-5753
Guangzhou Women and Children Medical Center · CNMinistry of Science and Technology · LAShanghai Children's Medical Center · CNShanghai Jiao Tong University · CNSun Yat-sen University · CN

Funding

Guangzhou Women and Children's Medical Center Internal Program 5001-1600006Guangzhou Women and Children's Medical Center Internal Program 5001-1600008Guangzhou Women and Children's Medical Center Internal Program 5001-160004Guangzhou Women and Children's Medical Center Internal Program IP-2018-001National Natural Science Foundation of China 32000392National Natural Science Foundation of China 81973997Natural Science Foundation of Guangdong Province 2015A030313460St. Baldrick's Foundation International Scholar 581580
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsparaginaseChildGATA3 Transcription FactorHumansNeoplasm, ResidualPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAsparaginaseGATA3 protein, humanGATA3 Transcription Factor

Identifiers

PMID34459144
PMCPMC8382977
OpenAlexW3194355124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.